Nanobiotix S.A. NBTX
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -0.60% | -22.34% | |||
| Total Other Revenue | -0.59% | 54.66% | |||
| Total Revenue | -0.59% | -6.31% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -0.59% | -6.31% | |||
| SG&A Expenses | -0.59% | 19.21% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.59% | 33.66% | |||
| Operating Income | 0.59% | -54.01% | |||
| Income Before Tax | 0.59% | -85.38% | |||
| Income Tax Expenses | -1.06% | 652.94% | |||
| Earnings from Continuing Operations | 0.59% | -85.50% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.59% | -85.50% | |||
| EBIT | 0.59% | -54.01% | |||
| EBITDA | 0.59% | -53.47% | |||
| EPS Basic | 0.58% | -83.01% | |||
| Normalized Basic EPS | 0.61% | -91.57% | |||
| EPS Diluted | 0.58% | -81.87% | |||
| Normalized Diluted EPS | 0.61% | -91.57% | |||
| Average Basic Shares Outstanding | 0.00% | 1.37% | |||
| Average Diluted Shares Outstanding | 0.00% | 1.37% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||